You are here

P&T News

September 19

Proprietary delivery system deposits proven steroid deep into the nose
Patient deaths related to other combination therapies concern the agency
Detailed procedures aim to protect patients from promising treatment’s toxicities
First once-daily, single-inhaler triple therapy for the disease in the U.S.
Such drugs often block the serotonin that other organs need

September 18

PFS worse with bendamustine and rituximab in new study
Single-dose oral therapy treats leading gynecological infection
Injection is also approved for GEP-NETs

September 15

Approval based on totality of evidence from global development program showing Mvasi is highly similar to Genentech’s Avastin
Panel believes GSK’s Shingrix represents an improvement over Merck’s Zostavax
In a clinical trial, the prescription-only adjunct treatment significantly increased patient adherence to abstinence

September 14

Options limited for patients, whose disease often returns
New study puts price of 10 cancer drugs at $648 million each
Vaccine protects against two A strain and two B strain viruses
Sotagliflozin may improve glucose control without increasing weight or hypoglycemia
Amicus won’t pursue wound-healing agent SD-101 for epidermolysis bullosa

September 12

New study examines impact of Medicaid changes

Pages